Upzon Drugs Private Limited
About Upzon Drugs Private Limited
Data last updated:
Upzon Drugs Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 June 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1996PTC010942. Its GSTIN is 23AAACU8671L1ZY (Madhya Pradesh).
The company has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Sushila Joshi and Ashok Joshi.
Its last annual general meeting (AGM) was held on 10 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M.P.L.U.N. Shed No. 32 Sector 'F' Sanwer Road, Indore, Madhya Pradesh, India – 452015.
As per the financials filed for FY 2025, the company reported a revenue of ₹52.74 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹28,530 (net margin 0.5%) and EBITDA of ₹55,190 (EBITDA margin 1%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Upzon Drugs Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressM.P.L.U.N. Shed No. 32 Sector 'F' Sanwer Road, Indore, Madhya Pradesh, India – 452015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Upzon Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Upzon Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Upzon Drugs Private Limited, buy the company report.
Financials of Upzon Drugs Private Limited
FY 2025 filings availableUpzon Drugs Private Limited reported revenue of ₹52.74 Lakh (down 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 32% fall in the latest year. EBITDA fell 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹55,190 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28,530 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Upzon Drugs Private Limited, buy the company report.
Board of directors of Upzon Drugs Private Limited
Upzon Drugs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushila Joshi | Director | 05 Jul 2017 | 9 Years 4 Months | Current |
| Ashok Joshi | Director | 19 Jun 1996 | 30 Years 4 Months | Current |
Auditor
Upzon Drugs Private Limited is audited by KVNG & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KVNG & Associates | FY 2024 | 02628C |
Shareholding
The shareholding of Upzon Drugs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Upzon Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Upzon Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Upzon Drugs Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 49 overdue payments to 31 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 31)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Tirupati Print O Pack | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Upzon Drugs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Upzon Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACU8671L1ZY | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Upzon Drugs Private Limited, buy the company report.
Recent activity
Upzon Drugs Private Limited has 3 board changes on record since 1996: 2 appointments and 1 cessation. The latest: Yogesh Sharma ceased to be Director on 22 Jul 2017.
Frequently asked questions
Upzon Drugs is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 June 1996 (30+ years old) and is registered under CIN U24232MP1996PTC010942.
Upzon Drugs has 2 current directors:
- Sushila Joshi - Director
- Ashok Joshi - Director
The latest financial statements of Upzon Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 10 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Upzon Drugs is 23AAACU8671L1ZY, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Upzon Drugs is U24232MP1996PTC010942. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Upzon Drugs was incorporated on 19 June 1996, making it 30+ years old. It is registered with the Registrar of Companies, Gwalior.
Yogesh Sharma ceased to be Director on 22 Jul 2017. Sushila Joshi was appointed as Director on 05 Jul 2017. Ashok Joshi was appointed as Director on 19 Jun 1996.
Upzon Drugs has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 49 overdue payments to 31 micro and small suppliers. The latest return was filed on 27 May 2019.
The registered office of Upzon Drugs is at M.P.L.U.N. Shed No. 32 Sector F Sanwer Road, Indore, Madhya Pradesh, India – 452015.
Upzon Drugs operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Upzon Drugs is compliant as of 22 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
